Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 102
Evaluation of the Markey Scholars Program Appendix E United Kingdom and Australian Visiting Fellows Richard J. Benjamin, Ph.D. Chief Medical Officer New England Region American Red Cross Boston, MA Claire Henchcliffe, Ph.D. Director Parkinson’s Institute at New York Hospital Cornell Medical Center New York, NY Ian J. Holt, Ph.D. Mitochondrial Diseases Group Leader MRC-Dunn Human Nutrition Unit Wellcome Trust-MRC Building Cambridge, United Kingdom Clare M. Huxley, Ph.D. Division of Biomedical Sciences Medicine Imperial College of Science Technology and Medicine London, United Kingdom
OCR for page 103
Evaluation of the Markey Scholars Program Jordan Raff, Ph.D. Department of Genetics Wellcome/CRC Institute Cambridge, United Kingdom Guy P. Vigers, Ph.D. Array BioPharma Boulder, CO Charles ffrench-Constant, Ph.D. Department of Pathology Wellcome/CRC Institute Cambridge, United Kingdom Kenneth Ramsey Howard, Ph.D. MRC-LMCB University College London, United Kingdom Stephen Philip Jackson, Ph.D. Professor Wellcome/CRC Institute Cambridge, United Kingdom Richard J. Epstein, Ph.D. Senior Lecturer Department of Metabolic Medicine Imperial College School of Medicine London, United Kingdom Simon M. Hughes, Ph.D. MRC Scientist MRC Muscle and Cell Motility Unit and Developmental Biology Research Centre The Randall Institute, King’s College London London, United Kingdom Anthony Hyman, Ph.D. Max Planck Institute of Molecular CBG Dresden, Germany
OCR for page 104
Evaluation of the Markey Scholars Program Richard M Durbin, Ph.D. Head of Informatics Division Department of Informatics Wellcome Trust Genome Campus Cambridge, United Kingdom Nigel T. Maidment, Ph.D. Associate Professor Department of Psychiatry and Behavioral Science University of California, Los Angeles Los Angeles, CA Laurence E. Reid, Ph.D. Millennium Pharmaceuticals Cambridge, MA Mark Rolfe, Ph.D. Director Mitotix, Inc. Cambridge, MA Alexander R. Duncan, Ph.D. Cambridge Antibody Technology, Ltd. Cambridgeshire, United Kingdom Elizabeth Macintyre-Davi, Ph.D. Chef de Service Hematologie Biologique Hopital Necker-Enfants Malades Paris, France Simon James Foote, Ph.D. Co-Director Australian Genome Research Facility, Genetics and Bioinformatics Group The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia Michelle D. Garrett, Ph.D. Team Leader Cancer Research UK Centre for Cancer Therapeutics at the Institute of Cancer Research 15 Cotswold Road, Sutton, United Kingdom
OCR for page 105
Evaluation of the Markey Scholars Program Kevin Hardwick, Ph.D. Research Group Leader Institute of Cell and Molecular Biology University of Edinburgh Edinburgh, United Kingdom Peter Leedman, Ph.D. Senior Lecturer in Medicine Lab for Cancer Medicine, WAIM University of Western Australia Perth, Western Australia, Australia Michael G. McHeyzer-Williams, Ph.D. Associate Professor Department of Immunology Scripps Research Institute La Jolla, CA Jonathan Millar, Ph.D. Division of Yeast Genetics National Institute for Medical Research London, United Kingdom Andrew Charles Perkins, Ph.D. Group Leader, Haematopoiesis Institute for Molecular Bioscience University of Queensland Brisbane, Queensland, Australia Linda Jane Richards, Ph.D. Associate Professor Department of Anatomy and Neurobiology University of Maryland, Baltimore School of Medicine Baltimore, MD Ann Marie Turnley, Ph.D. Centre for Neuroscience The University of Melbourne Melbourne, Victoria, Australia
OCR for page 106
Evaluation of the Markey Scholars Program David L. Vaux, Ph.D. Cell Death Laboratory The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia John Gubbay, Ph.D. Royal Free Hospital and School of Medicine London, United Kingdom Paul Michael Waring, Ph.D. Department of Pathology University of Melbourne Melbourne, Victoria, Australia Katherine Watson, Ph.D. (nee Katherine Ann Kelly) Riddell’s Creek, Victoria, Australia Anamitra Bhattacharyya, Ph.D. Group Leader for Genome Analysis Integrated Genomics, Inc. Chicago, IL Andrew Chisholm, Ph.D. Associate Professor Department of Molecular, Cellular and Developmental Biology University of California Santa Cruz, CA Douglas J. Hilton, Ph.D. Senior Research Fellow Cancer Research Unit The Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia Neil McDonald, Ph.D. Structural Biology Laboratory London Research Institute London, United Kingdom
OCR for page 107
Evaluation of the Markey Scholars Program Andrew David Randall, Ph.D. Neurology CEDD GlaxoSmithKline Essex, United Kingdom
Representative terms from entire chapter: